Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001516743 | SCV001725074 | benign | Granulomatous disease, chronic, X-linked | 2023-11-13 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001826367 | SCV002087126 | likely benign | Chronic granulomatous disease | 2020-01-30 | no assertion criteria provided | clinical testing | |
Prevention |
RCV004753354 | SCV005354856 | likely benign | CYBB-related disorder | 2024-07-18 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |